mannitol has been researched along with itraconazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dressman, JB; Hesse, U; Uch, AS | 1 |
| Johnston, KP; McConville, JT; Miller, DA; Tam, J; Williams, RO; Yang, W; Zhou, J | 1 |
| Amighi, K; Duret, C; Sebti, T; Vanderbist, F; Wauthoz, N | 2 |
| Amighi, K; Duret, C; Goole, J; Maris, C; Merlos, R; Roland, I; Sebti, T; Vanderbist, F; Wauthoz, N | 1 |
| Li, LC; Mao, S; Ni, R; Sun, W; Zhang, X | 1 |
| Burgess, DJ; Jog, R; Kumar, S; Sadrieh, N; Shen, J; Zolnik, B | 1 |
| Huang, Z; Lin, L; Lu, M; Peng, T; Quan, G; Singh, V; Wu, C | 1 |
| McComiskey, KPM; McDonagh, A; Tajber, L | 1 |
| Afzal, Z; Asghar, S | 1 |
1 review(s) available for mannitol and itraconazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for mannitol and itraconazole
| Article | Year |
|---|---|
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Use of 1-methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs.
Topics: Animals; Antifungal Agents; Hydrocortisone; Intestinal Absorption; Itraconazole; Male; Mannitol; Molecular Weight; Pyrrolidinones; Rats; Rats, Wistar; Solubility; Time Factors | 1999 |
High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers.
Topics: Administration, Inhalation; Aerosols; Animals; Antifungal Agents; Biological Availability; Chemistry, Pharmaceutical; Excipients; Freezing; Half-Life; Itraconazole; Lecithins; Lung; Male; Mannitol; Mice; Mice, Inbred ICR; Nanoparticles; Permeability; Solubility; Tissue Distribution | 2008 |
Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
Topics: Administration, Inhalation; Aerosols; Antifungal Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Compounding; Excipients; Itraconazole; Mannitol; Particle Size; Polyethylene Glycols; Powders; Solubility; Transition Temperature; Vitamin E; X-Ray Diffraction | 2012 |
In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Evaluation, Preclinical; Dry Powder Inhalers; Excipients; Itraconazole; Lasers; Lung; Male; Mannitol; Mice; Mice, Inbred ICR; Microscopy, Fluorescence; Particle Size; Phospholipids; Reproducibility of Results; Scattering, Radiation; Tissue Distribution | 2012 |
New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Invasive Pulmonary Aspergillosis; Itraconazole; Mannitol; Microscopy, Electron, Scanning; Particle Size; Phospholipids; Powders; Solubility; Solutions; X-Ray Diffraction | 2012 |
Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
Topics: Administration, Oral; Animals; Antifungal Agents; Biological Availability; Chemistry, Pharmaceutical; Crystallization; Dogs; Excipients; Feasibility Studies; Itraconazole; Male; Mannitol; Nanoparticles; Particle Size; Powders; Solubility; Tablets; Water; X-Ray Diffraction | 2015 |
In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
Topics: Animals; Biological Availability; Chemistry, Pharmaceutical; Excipients; Itraconazole; Mannitol; Nanoparticles; Nanotechnology; Particle Size; Povidone; Powders; Rats; Sodium Dodecyl Sulfate; Solubility; Suspensions | 2015 |
Development of fine solid-crystal suspension with enhanced solubility, stability, and aerosolization performance for dry powder inhalation.
Topics: Aerosols; Antifungal Agents; Crystallization; Drug Compounding; Drug Liberation; Drug Stability; Dry Powder Inhalers; Itraconazole; Mannitol; Particle Size; Powders; Solubility; Suspensions | 2017 |
Isolation of Itraconazole Nanostructured Microparticles via Spray Drying with Rational Selection of Optimum Base for Successful Reconstitution and Compaction.
Topics: Desiccation; Excipients; Itraconazole; Mannitol; Nanostructures; Particle Size; Powders; Tablets; Tensile Strength; Trehalose | 2019 |
Fabrication and characterization of itraconazole loaded anisotropic solid lipid-mannitol microstructures for enhanced antifungal activity.
Topics: Antifungal Agents; Candida albicans; Drug Compounding; Drug Liberation; Itraconazole; Lipids; Mannitol; Microscopy, Electron, Scanning | 2021 |